Jump to content

Alopecia Treatment: Androgenetic Baldness Medication Study Completed


gmonasco

Recommended Posts

  • Senior Member

Announced recently was the completion of R-Tech Ueno’s Phase 2a study of its alopecia treatment medication, RK-023. This is treatment for baldness is focused on the androgenetic type which currently has no topical drug available in the market.

 

Alopecia Treatment: Androgenetic Baldness Medication Study Completed « Rillara News

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...